Delivery Order SPE2DB25D3003-SPE2DB25FPWJX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,577.56 to AmerisourceBergen Drug Corp for Sumatriptan 20 mg nasal sprays on August 12, 2025, with final delivery required by August 13, 2025. This is a firm fixed-price, non-competitive delivery order issued without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 20 mg nasal sprays valued at $2,743.77, with an ultimate completion date of August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 5 mg nasal sprays with a ceiling value of $1,010.98. The contract, issued on October 30, 2025, with completion due October 31, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Sumatriptan 20 mg nasal sprays, with a ceiling value of $1,761.21 and a completion date of May 14, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Sumatriptan 20 mg nasal sprays, a migraine medication, with a ceiling value of $2,009.88. This delivery order represents a firm fixed-price, non-set-aside competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The place of performance is located at the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4,568,983,540 units of Sumatriptan 20 mg nasal spray, with a ceiling value of $4,342.91 under firm fixed price terms. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and is classified as a non-set-aside, competitively awarded contract. Performance will be conducted at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 5 mg nasal sprays with a ceiling value of $2,234.40 under a firm fixed-price contract type. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a competitively awarded, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,059.91 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 5mg nasal spray (6-count units) on August 19, 2025, with completion targeted for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 20 mg nasal sprays valued at $1,758.62 with a firm fixed price structure. The contract, which was competitively awarded without a set-aside designation, was executed on May 27, 2025, with an ultimate completion date of May 28, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,301,212 units of Sumatriptan 20 mg nasal sprays. The $3,484.38 order has a January 12, 2024 completion date and was awarded on January 11, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals and...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPWJXDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 14, 2025, for the supply of Sumatriptan 20 mg nasal sprays, with a ceiling value of $22,839.49 and a completion date of May 15, 2025. This delivery order represents a non-set-aside competitive award and falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability in delivering a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order for migraine treatment medication supports the Defense Health Agency and other government healthcare systems through the company's established prime vendor relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.8k | 5/14/25 |